Literature DB >> 6301625

Botulinum toxin blocks quantal but not non-quantal release of ACh at the neuromuscular junction.

E F Stanley, D B Drachman.   

Abstract

Botulinum (BOT) toxin is known to block quantal acetylcholine (ACh) release at the neuromuscular junction but little is known about its effect on non-quantal ACh release. We have examined the effect of BOT on non-quantal ACh release directly using a variant of the electrophysiological technique described by Katz and Miledi. This method is based on the observation that non-quantally released ACh results in a small, continual depolarization of the postsynaptic membrane, after inhibition of cholinesterase. This depolarization can be revealed by suddenly blocking ACh receptors with a pulse of curare, resulting in an abrupt hyperpolarization, the amplitude of which is presumed to be proportional to the rate of non-quantal ACh release. BOT treatment resulted in a marked decrease in quantal ACh release as shown by miniature endplate potential (m.e.p.p.) frequencies (control 0.65 +/- 0.33 m.e.p.p.s/s; BOT 0.03 +/- 0.03 m.e.p.p.s/s). However, non-quantal ACh release measured by the curare induced hyperpolarization, was not significantly different in control and BOT treated diaphragms (control 1.01 +/- 0.09 mV: BOT 1.03 +/- 0.11 mV). Our results show that BOT does not block non-quantal ACh release at a time when it has a profound effect on spontaneous quantal ACh release. This suggests that quantal and non-quantal ACh release take place through different release mechanisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301625     DOI: 10.1016/0006-8993(83)91300-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Function Suggests Nano-Structure: Quantitative Structural Support for SNARE-Mediated Pore Formation.

Authors:  Ilan Hammel; Isaac Meilijson
Journal:  Neurotox Res       Date:  2015-09-25       Impact factor: 3.911

Review 2.  A review on use of botulinum toxin for intractable lacrimal drainage disorders.

Authors:  Swati Singh; Mohammad Javed Ali; Friedrich Paulsen
Journal:  Int Ophthalmol       Date:  2017-08-01       Impact factor: 2.031

3.  Botulinum toxin prevents stimulus-induced backfiring produced by neostigmine in the mouse phrenic nerve-diaphragm.

Authors:  E Aizenman; G G Bierkamper; E F Stanley
Journal:  J Physiol       Date:  1986-03       Impact factor: 5.182

4.  Accumulation of extracellular calcium at the endplate of mouse diaphragm after ecothiopate in vitro.

Authors:  P F Burd; C B Ferry; J W Smith
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

5.  Neural regulation of acetylcholine receptors in rat neonatal muscle.

Authors:  L L Bambrick; T Gordon
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

6.  Botulinum toxin.

Authors:  P K Nigam; Anjana Nigam
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

7.  Botulinum toxin inhibits quantal acetylcholine release and energy metabolism in the Torpedo electric organ.

Authors:  Y Dunant; J E Esquerda; F Loctin; J Marsal; D Muller
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

8.  Is an acetylcholine transport system responsible for nonquantal release of acetylcholine at the rodent myoneural junction?

Authors:  C Edwards; V Dolezal; S Tucek; H Zemková; F Vyskocil
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Neural regulation of [3H]saxitoxin binding site numbers in rat neonatal muscle.

Authors:  L L Bambrick; T Gordon
Journal:  J Physiol       Date:  1988-12       Impact factor: 5.182

10.  Enhancement by calcitonin gene-related peptide of nicotinic receptor-operated noncontractile Ca2+ mobilization at the mouse neuromuscular junction.

Authors:  I Kimura; H Tsuneki; K Dezaki; M Kimura
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.